Therapeutic products comprising vitalized placental dispersions

A therapeutic placental product comprising:

• a. placental cells in an amount at least about 10,000 per ml of placental product;
• and
• b. placental factors comprising one or more extracellular matrix proteins, one or more protease inhibitors, one or more growth factors, one or more angiogenic factors, and one or more MMPs;
• wherein the therapeutic placental product is a dispersion and wherein the placental factors are chorionic placental factors.

A therapeutic placental product comprising:

• a. placental cells in an amount of at least about 10,000 per ml of placental product;
• and
• b. placental factors comprising one or more members of the group consisting of extracellular matrix proteins, protease inhibitors, growth factors, angiogenic factors, and MMPs,
• wherein the placental product is a dispersion and wherein the placental factors are chorionic placental factors.

A therapeutic placental product comprising:

• a. placental cells in at least about 10,000 per ml of placental product;
• and
• b. placental factors comprising one or more members of the group consisting of fibronectins, TIMPs, TGFs, bFGF, and MMPs,
• wherein the placental product is a dispersion and wherein the placental factors are chorionic placental factors.